Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Infectious Diseases|July 3, 2008
Vaccination after stem cell transplant: a review of recent developments and implications for current practiceMarissa B Wilck, Lindsey R Baden
Human Vaccines & Immunotherapeutics|August 5, 2020
Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infantsMarissa B Wilck, Z Jin Xu, Jon E Stek, et al.
Vaccine|February 5, 2021
Protective immune responses against Haemophilus influenza type b elicited by a fully-liquid DTaP-IPV-Hib-HepB vaccine (VAXELIS™)Marissa B Wilck, Z Jin Xu, Jon E Stek, et al.
Human Vaccines & Immunotherapeutics|June 2, 2022
Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previouslyAnitta Ahonen, Ying Zhang, Tomáš Marček, et al.
Journal of the American Academy of Dermatology|October 1, 2013
From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasisLara Wine-Lee, Sara C Keller, Marissa B Wilck, et al.
The Lancet. Infectious Diseases|January 13, 2012
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trialMohamed A Kharfan-Dabaja, Michael Boeckh, Marissa B Wilck, et al.
The Journal of Infectious Diseases|March 31, 2010
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administrationMarissa B Wilck, Michael S Seaman, Lindsey R Baden, et al.
The Journal of Infectious Diseases|March 31, 2010
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with DryvaxMichael S Seaman, Marissa B Wilck, Lindsey R Baden, et al.
The Journal of Infectious Diseases|March 14, 2013
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trialStephen R Walsh, Marissa B Wilck, David J Dominguez, et al.
The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Pageof 1